Tanaka E, Nakamura K
Institute of Community Medicine, University of Tsukuba, Japan.
Eur J Clin Pharmacol. 1989;36(6):629-32. doi: 10.1007/BF00637749.
Ten healthy male volunteers were given trimethadione (TMO) 4 mg/kg and antipyrine (AP) 500 mg alone or concomitantly to determine whether the metabolism of the drugs was mediated by the same or closely related forms of cytochrome P-450. Whether administered alone or together the clearance (CL) and half-life (t 1/2) of TMO and AP were the same, and there was a good correlation between the CL and t 1/2 of TMO and AP (alone r = 0.755 and 0.623, respectively; coadministered r = 0.771 and 0.503, respectively). Excretion of AP and its main metabolite and the clearance for production of AP metabolites after AP was administered alone were not significantly different when TMO and AP were taken together. When the two drugs were administered alone or coadministered, the correlation between the CL of TMO and the excretion of 3-hydroxymethyl-3-norantipyrine (NORA) was close (alone r = 0.734, coadministered r = 0.749). The correlation between the CL of TMO and CLm of NORA when TMO and AP were given alone or concomitantly was 0.762 and 0.772, respectively. The findings suggest that TMO metabolism and the formation of NORA in healthy subjects are mediated by a closely related form(s) of the cytochrome P-450 system.
给10名健康男性志愿者单独或同时服用4mg/kg的三甲双酮(TMO)和500mg的安替比林(AP),以确定这些药物的代谢是否由细胞色素P-450的相同或密切相关形式介导。无论单独给药还是联合给药,TMO和AP的清除率(CL)和半衰期(t 1/2)均相同,且TMO和AP的CL与t 1/2之间存在良好的相关性(单独给药时r分别为0.755和0.623;联合给药时r分别为0.771和0.503)。单独服用AP时,AP及其主要代谢产物的排泄以及AP代谢产物生成的清除率在与TMO联合服用时无显著差异。单独或联合给予这两种药物时,TMO的CL与3-羟甲基-3-去甲安替比林(NORA)的排泄之间的相关性密切(单独给药时r = 0.734,联合给药时r = 0.749)。单独或同时给予TMO和AP时,TMO的CL与NORA的CLm之间的相关性分别为0.762和0.772。这些发现表明,健康受试者中TMO的代谢和NORA的形成由细胞色素P-450系统的密切相关形式介导。